Why Hypoxic Burden Predicts Your Heart Risk Better Than the AHI Number on Your Sleep Report
How hypoxic burden sleep apnea data explains the heart risk your AHI number hides
Your sleep report holds a second number that tracks cardiovascular risk far more closely than the AHI, and European labs are already recording the signal behind it.
Hypoxic Burden Sleep Apnea Explained in Under a Minute
Hypoxic burden is the total amount of oxygen your blood loses during breathing events, counted per hour of sleep and written in %min/h (percent-minutes per hour). Hypoxic burden sleep apnea research answers the question your AHI cannot: not how often you stopped breathing, but how deep and how long each oxygen drop ran. In two cohorts totalling 7,854 adults, hypoxic burden predicted cardiovascular mortality and the apnoea-hypopnoea index (AHI) did not (Azarbarzin et al., European Heart Journal, 2019). A modest AHI can therefore sit next to real risk, which is why what your AHI score actually measures is only half of your report.
Your report probably does not print the value. European labs usually show the apnoea-hypopnoea index (printed IAH, indice d'apnées-hypopnées, on a French report), the oxygen desaturation index (ODI), T90 and nadir SpO2 instead. Those four lines carry much of the same signal, so knowing how a sleep apnoea diagnosis is actually put together is the practical workaround. An estimated 425 million adults aged 30-69 have moderate-to-severe obstructive sleep apnoea worldwide (Benjafield et al., The Lancet Respiratory Medicine, 2019). Almost none of them have seen this metric.
- Hypoxic burden sleep apnea data measures oxygen loss; the AHI only counts events.
- Cardiovascular signal sits in the depth and length of your desaturations.
- If your lab does not report it, ODI, T90 and nadir SpO2 are your proxies.
What Hypoxic Burden Measures That the AHI Cannot
Hypoxic burden is the area under the desaturation curve, summed across every respiratory event and divided by hours of sleep. Picture each dip in your overnight SpO2 trace as a valley. The AHI counts valleys. Hypoxic burden measures the space inside them.
That gap is physiological, not cosmetic. A brief shallow dip and a long deep one can score identically in the apnoea-hypopnoea index. They are not the same load. The version scored strictly from breathing events is written SASHB, sleep apnoea-specific hypoxic burden, and it isolates the oxygen lost to your apnoea rather than to lung disease or obesity-related hypoventilation.
Repeated deep dips produce the pattern researchers call intermittent hypoxia, a night-long cycle of falling and rebounding saturation. Oxidative stress and sympathetic activation are the mechanisms most often proposed to explain why nocturnal hypoxaemia is linked to sleep apnea and heart disease, resistant hypertension and atrial fibrillation. The hypoxic burden sleep apnea association is consistent across cohorts. It is not proof of cause in any one patient.
| Metric on your report | What it counts | Unit | Blind spot |
|---|---|---|---|
| Apnoea-hypopnoea index (AHI / IAH) | Apnoeas and hypopnoeas per hour of sleep | events/h | How deep and how long each desaturation went |
| Oxygen desaturation index (ODI) | Drops in SpO2 past a set trigger, per hour | events/h | Depth below the trigger, and duration |
| T90 | Sleep time spent with SpO2 below 90% | % of sleep | Which of those minutes came from breathing events |
| Nadir SpO2 | Lowest oxygen saturation of the night | % | Everything except one instant |
| Hypoxic burden (SASHB) | Area under each respiratory event-related desaturation | %min/h | Micro-arousals, fragmentation and daytime symptoms |
- Two people with the same AHI can have very different oxygen loss.
- SASHB strips out desaturation that is not caused by your apnoea.
- No single metric describes a night; read AHI and oxygen lines together.
Two Things Most Hypoxic Burden Sleep Apnea Guides Get Wrong
The first flaw is numerical silence. Nearly every page ranking for this term cites the same landmark 2019 study, then leaves out every figure inside it. No hazard ratios. No confidence intervals. No cohort sizes. At least one ranking explainer credits the paper to the wrong journal: it appeared in the European Heart Journal, the official journal of the European Society of Cardiology (2019;40:1149-1157, doi 10.1093/eurheartj/ehy624). A page that misplaces the journal is not a page to take thresholds from.
The second flaw is geography. The standard argument rests on two American research cohorts recruited in the 1990s, the Sleep Heart Health Study (SHHS) and the MrOS Sleep Study, one of them exclusively older men with a mean age of 76.3. You were diagnosed in a European clinic this decade, most likely by respiratory polygraphy (polygraphie ventilatoire) or full polysomnography (polysomnographie). The largest real-world clinical evidence fits you far better. It is French.
- Demand the effect size, not just the name of the study.
- 1990s research-cohort data is a weak match for a 2026 European patient.
- The biggest sleep-clinic cohort on this metric is the French Pays de la Loire cohort.
What the Hypoxic Burden Sleep Apnea Cohorts Actually Found
Across four cohorts on two continents, hypoxic burden tracked cardiovascular outcomes in analyses where the AHI did not. Here are the numbers the ranking pages leave out.
Cardiovascular mortality
In MrOS (2,743 men, mean age 76.3), the highest hypoxic-burden quintile carried a hazard ratio of 2.73 for cardiovascular death (95% CI 1.71-4.36). In the Sleep Heart Health Study (5,111 adults, 52.8% women, mean age 63.7), the top quintile ran at 1.96 (95% CI 1.11-3.43). The AHI predicted neither (Azarbarzin et al., European Heart Journal, 2019).
Major adverse cardiovascular events
The French Pays de la Loire sleep cohort followed 5,358 patients with newly diagnosed OSA and no overt cardiovascular disease for a median of 78 months, linked to national health administrative data. There were 592 major adverse cardiovascular events (MACE), 11.05% of the cohort. In the fully adjusted model, hypoxic burden (HR 1.21, 95% CI 1.07-1.38) and T90 (HR 1.34, 95% CI 1.16-1.55) were the only predictors of MACE. Symptom subtypes were not associated after adjustment (Trzepizur et al., American Journal of Respiratory and Critical Care Medicine, 2022).
Sweden's RICCADSA cohort tested the same idea in 368 adults with an AHI of 15 or more, followed a median of 4.7 years. High hypoxic burden, split at the cohort median of 60.7 %min/h, was associated with major adverse cardiac and cerebrovascular events, or MACCE (adjusted HR 1.87, 95% CI 1.17-2.98, P=.009). An AHI of 30 or more was not (P=.366) (Chest, 2025).
Incident heart failure
Sleep apnoea-specific hypoxic burden predicted incident heart failure in men in both SHHS (n=4,881) and MrOS (n=2,653), with adjusted hazard ratios of 1.18 and 1.22 per standard-deviation increase, where the AHI did not. The association held across AHI levels. It was not significant in women (Azarbarzin et al., Chest, 2020).
- Four independent cohorts, one consistent direction, across mortality, MACE and heart failure.
- Effect sizes are moderate per standard deviation and large at the extremes.
- Evidence in women is thinner; several signals were significant only in men.
What Counts as a High Hypoxic Burden
There is no agreed cut-off, and that is the honest answer nobody prints. Three credible studies use three different high-risk thresholds. Every hypoxic burden sleep apnea cut-off in print was built for a different population and a different question.
| Threshold | Study and year | Population | What it defined |
|---|---|---|---|
| Above 40.6 %min/h | Pays de la Loire cohort linked to the SNDS, European Respiratory Journal, 2026 | 3,370 PAP-treated moderate-to-severe OSA patients, France | High-risk status, alongside an event-related heart rate response above 21.7 bpm |
| 60.7 %min/h (cohort median) | RICCADSA, Chest, 2025 | 368 Swedish adults with AHI 15 or more | The split between high and low hypoxic burden |
| Above 87.1 %min/h | Pooled RICCADSA, ISAACC and SAVE analysis, European Heart Journal, 2026 | 3,549 participants in three CPAP trials (Sweden, Spain, Australia) | High-risk OSA, alongside a heart rate response above 9.4 bpm |
A median split describes one cohort. It is not a clinical band. The pooled-trial value separated high-risk from low-risk participants inside randomised CPAP trials, a different job again. Three defensible answers to three different questions is exactly why no European guideline has adopted one.
- Published high-risk thresholds range from 40.6 to 87.1 %min/h.
- Compare your value to the study whose population resembles you.
- Treat any single printed cut-off as a research reference, not a verdict.
When a High AHI Is Less Frightening Than It Looks
A high AHI paired with shallow desaturations was not associated with increased cardiac risk in the Swedish data. RICCADSA's four-way analysis found that high hypoxic burden was associated with major adverse cardiac and cerebrovascular events regardless of AHI level, while a high AHI combined with low hypoxic burden showed no increased risk (Chest, 2025). An AHI of 34 with brief, shallow dips is a different animal from an AHI of 34 with long ones.
The mirror case is harder, and it is why most people search for hypoxic burden sleep apnea at all. An AHI of 12 sits in the mild band under NICE NG202. Deep, prolonged desaturations underneath that number are not mild. Checking what your oxygen levels during sleep should look like is the step that separates the two situations on paper.
- High AHI with low hypoxic burden showed no excess cardiac risk in RICCADSA.
- High hypoxic burden mattered whatever the AHI said.
- Mild on the AHI scale does not automatically mean mild oxygen loss.
Why a Hypoxic Burden Sleep Apnea Result Changes Your Urgency and Not Your Entitlement
In France and the UK, what you are entitled to is still decided on the AHI. Hypoxic burden appears in neither rulebook, and almost no page says so plainly.
French Assurance Maladie criteria reimburse PPC (pression positive continue, the French term for CPAP) at an IAH of 30 or more, or an IAH of 15-30 combined with at least 10 micro-eveils per hour or documented serious cardiovascular disease such as resistant hypertension, recurrent atrial fibrillation, severe heart failure or prior stroke. Use must reach a minimum of three hours per night, renewed annually. The orthèse d'avancée mandibulaire (OAM, a mandibular advancement device) is the reimbursed first-line option for an IAH of 15-30 without cardiovascular disease, or after PPC failure or intolerance. Renewal at two years requires a demonstrated reduction of at least 50% in the apnoea-hypopnoea index.
So the French payer measures your treatment success in the very metric with the weaker cardiovascular signal. In the UK, NICE NG202 bands severity as mild (AHI 5 to under 15), moderate (15 to under 30) and severe (30 or above), and recommends CPAP for adults with moderate or severe symptomatic OSAHS. Hypoxic burden is absent from the guideline.
What you are offered for mild-to-moderate disease also depends on where you live. Across European centres in the ESADA registry (European Sleep Apnoea Database), PAP was recommended in 65.5% of mild-to-moderate cases and a mandibular advancement device in 34.5%, but device recommendation ranged from 0% to 76% between centres, driven by accessibility and local reimbursement rather than severity alone (ESADA study group, ERJ Open Research, 2025).
- Eligibility for PPC and OAM runs on AHI thresholds, not oxygen load.
- A high hypoxic burden is an argument for faster follow-up, not for entitlement.
- Mild-to-moderate care varies enormously between European centres.
How to Get Your Hypoxic Burden Number
Ask which system recorded your night. Two European diagnostic platforms already compute the value. CIDELEC (Sainte-Gemmes-sur-Loire, France) calculates hypoxic burden automatically and displays it in the recording summary with a scale drawn from published literature. It describes the metric as a biomarker that complements the apnoea-hypopnoea index. Noxturnal software from Nox Medical (Reykjavik, Iceland) provides hypoxic burden as an informational parameter.
- Which system recorded my study, and was it polysomnography, respiratory polygraphy or a home sleep apnoea test (HSAT)?
- Does that software report a hypoxic burden or SASHB value, and can it be added to my report?
- If it cannot, what are my ODI, T90, nadir SpO2 and arousal index, and what share of my events were obstructive?
Hypoxic burden sleep apnea scoring is done by software, not by hand. It needs the raw SpO2 signal with every breathing event annotated. A printed summary page cannot produce it. Neither can a wearable. NICE NG202 is blunt on that point: do not use oximetry alone to diagnose OSAHS or nocturnal hypoventilation. Overnight pulse oximetry (oximetrie nocturne), smartwatch data and an Epworth Sleepiness Scale score are useful context for your consultation, not a diagnosis.
- Two European software platforms already calculate hypoxic burden.
- You cannot derive it by hand or from a consumer oximeter trace.
- Asking your lab which system was used costs one phone call.
Your Two-Week Plan After a Confusing Sleep Report
1Pull your four oxygen lines
Write down AHI or IAH, ODI, T90 and nadir SpO2 on one page. If T90 is high while the AHI looks mild, that mismatch is the conversation to have.
2Ask the lab for the burden value
Use the three questions above. Name the software. Labs answer that far faster than a vague request for detail.
3Separate urgency from entitlement
List your arousal index (micro-eveils), your Epworth score and any cardiovascular history. Those items decide reimbursement in France. Your hypoxic burden sleep apnea data decides how hard you push for an earlier appointment.
4If your burden is high, push for PAP
Treatment benefit appears concentrated in exactly this group. In the pooled analysis of RICCADSA, ISAACC and SAVE, CPAP was associated with a hazard ratio of 0.83 (95% CI 0.66-1.05) in high-risk OSA versus 1.22 (95% CI 0.96-1.54) in low-risk OSA, interaction HR 0.69 (95% CI 0.50-0.95, P=0.024), strengthening to 0.59 (95% CI 0.41-0.84) in patients without excessive daytime sleepiness (European Heart Journal, 2026). In 3,370 French PAP-treated patients, PAP adherence of at least four hours a night was associated with an adjusted hazard ratio of 0.53 for MACE (95% CI 0.46-0.62, p<0.001), with a stronger association in the high-risk group (European Respiratory Journal, 2026).
5If both numbers are low, treat the snoring
When your AHI sits in the mild band, your desaturations are shallow and nasal obstruction drives the snoring, conservative options are reasonable: side sleeping, alcohol timing, nasal-route measures. Back2Sleep is one of them, a CE-certified Class I soft silicone nasal stent (dilatateur nasal) that keeps the nasal airway open during sleep, sold without a prescription in a four-size starter kit.
- Two weeks is enough to get your oxygen data and a follow-up booked.
- High burden means push for PAP and stay adherent above four hours a night.
- Low burden with snoring is where conservative nasal measures belong.
What Back2Sleep Users Say
Frequently Asked Questions
What is hypoxic burden on a sleep study?
Hypoxic burden is the total oxygen your blood loses during breathing events each hour of sleep, measured in %min/h. It is the area under the oxygen desaturation curve, so it captures how deep and how long each drop went rather than simply counting events the way the apnoea-hypopnoea index does.
What is a normal hypoxic burden value?
No guideline defines one. Three studies use three different high-risk thresholds: above 40.6 %min/h in the French Pays de la Loire cohort (European Respiratory Journal, 2026), a 60.7 %min/h median split in Sweden's RICCADSA cohort (Chest, 2025), and above 87.1 %min/h in a pooled trial analysis (European Heart Journal, 2026).
Is hypoxic burden a better predictor of heart problems than AHI?
For cardiovascular outcomes, the evidence says yes. Across 7,854 adults in two cohorts, the highest hypoxic-burden quintile carried hazard ratios of 2.73 and 1.96 for cardiovascular death while the AHI predicted neither (Azarbarzin et al., European Heart Journal, 2019). The AHI still decides your severity band and your reimbursement.
Why do I feel terrible when my AHI is only mild?
Mild by AHI does not mean mild oxygen loss. Long, deep desaturations can hide under an AHI of 12. In 5,358 French patients, hypoxic burden and T90 were the only predictors of major cardiac events after adjustment (American Journal of Respiratory and Critical Care Medicine, 2022). Ask for your oxygen figures.
Can I calculate my hypoxic burden myself if it is not on my report?
Not by hand. The calculation needs the raw SpO2 signal with every breathing event annotated, which only scoring software can do. CIDELEC in France computes it automatically and displays it in the recording summary, and Noxturnal from Nox Medical supplies it as an informational parameter. Ask which system recorded your night.
Can a home sleep apnea test measure hypoxic burden?
Sometimes. A home sleep apnoea test that records SpO2 with scored breathing events can produce it, provided the analysis software supports the parameter. A wrist wearable or a standalone oximeter cannot. NICE NG202 states plainly that oximetry alone must not be used to diagnose OSAHS or nocturnal hypoventilation.
Does treating sleep apnea lower your heart risk if your hypoxic burden is high?
The benefit looks concentrated there. A pooled analysis of three CPAP trials found an interaction hazard ratio of 0.69 favouring high-risk OSA (European Heart Journal, 2026), and among 3,370 French patients, PAP use of at least four hours nightly was associated with a 0.53 hazard ratio for cardiac events (European Respiratory Journal, 2026).
Does hypoxic burden predict heart failure?
In men, yes. Sleep apnoea-specific hypoxic burden predicted incident heart failure in both the Sleep Heart Health Study and MrOS, with adjusted hazard ratios of 1.18 and 1.22 per standard-deviation increase, where the AHI did not (Azarbarzin et al., Chest, 2020). It was not significant in women.
Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.
Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.
Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.